Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice
ConclusionsThis TTFields safety surveillance analysis in> 11,000 patients revealed no new safety concerns, with a favorable safety profile comparable with published TTFields/GBM trials. The safety profile remained consistent among subgroups, suggesting feasibility in multiple populations, including elderly patients.
Source: Journal of Neuro-Oncology - Category: Cancer & Oncology Source Type: research
More News: African Health | Astrocytoma | Brain | Brain Cancers | Brain Tumor | Cancer & Oncology | Glioma | Headache | Japan Health | Middle East Health | Migraine | Neurology | Pediatrics | Skin